美国 · SEC FORM 4
HAEMONETICS CORP
HAE · NYSE · CIK 0000313143 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
25 同一窗口内观察到的 Form 4 交易行
0 sales · 25 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 9 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-10 · KROLL MARK W.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,037,763
- 上期报告
- 3,424,696
- 日均成交量
- 569,315
- 回补天数
- 5.3
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
27 transaction lines in the latest 365-day window; 401 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Zane Ellen M | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | Pomeroy Claire | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | Madaus Martin D | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (27 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Zane Ellen M | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | Pomeroy Claire | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | Madaus Martin D | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | KROLL MARK W | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | Johnson Lloyd Emerson | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | COYLE MICHAEL J | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | Bryant Diane M | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-24 | ABERNATHY ROBERT E | 奖励／授予 (A) | Common Stock | 2,538 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-05 | Miller Laurie A. | 代扣税 (F) | Common Stock | 313 | USD 71.28 | USD 22,311 | SEC 申报 ↗ |
| 2026-06-05 | Maunsell Farris Maryanne | 代扣税 (F) | Common Stock | 259 | USD 71.28 | USD 18,462 | SEC 申报 ↗ |
| 2026-05-15 | Simon, Christopher | 代扣税 (F) | Common Stock | 9,681 | USD 56.29 | USD 544,943 | SEC 申报 ↗ |
| 2026-05-15 | Simon, Christopher | 奖励／授予 (A) | Common Stock | 78,344 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Miller Laurie A. | 代扣税 (F) | Common Stock | 948 | USD 56.29 | USD 53,363 | SEC 申报 ↗ |
| 2026-05-15 | Miller Laurie A. | 奖励／授予 (A) | Common Stock | 13,323 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Maunsell Farris Maryanne | 代扣税 (F) | Common Stock | 197 | USD 56.29 | USD 11,089 | SEC 申报 ↗ |
| 2026-05-15 | Maunsell Farris Maryanne | 奖励／授予 (A) | Common Stock | 2,220 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Galvin Roy | 代扣税 (F) | Common Stock | 879 | USD 56.29 | USD 49,479 | SEC 申报 ↗ |
| 2026-05-15 | Galvin Roy | 奖励／授予 (A) | Common Stock | 27,535 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | DArecca James | 代扣税 (F) | Common Stock | 2,505 | USD 56.29 | USD 141,006 | SEC 申报 ↗ |
| 2026-05-15 | DArecca James | 奖励／授予 (A) | Common Stock | 29,312 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Chan Frank | 代扣税 (F) | Common Stock | 546 | USD 56.29 | USD 30,734 | SEC 申报 ↗ |
| 2026-05-15 | Chan Frank | 奖励／授予 (A) | Common Stock | 27,535 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Basil Michelle L | 代扣税 (F) | Common Stock | 2,913 | USD 56.29 | USD 163,973 | SEC 申报 ↗ |
| 2026-05-15 | Basil Michelle L | 奖励／授予 (A) | Common Stock | 28,424 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-01 | DArecca James | 代扣税 (F) | Common Stock | 655 | USD 59.26 | USD 38,815 | SEC 申报 ↗ |
| 2025-11-10 | KROLL MARK W | 买入 (P) | Common Stock | 1,400 | USD 70.56 | USD 98,784 | SEC 申报 ↗ |
| 2025-10-31 | Galvin Roy | 代扣税 (F) | Common Stock | 145 | USD 50.01 | USD 7,251 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | HAE |
| CIK | 0000313143 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 401 transaction lines from 2020-03-06 to 2026-07-24 2 P purchase lines · 135 S sale lines · 264 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.